Internal Medicine, Infectious Disease · Delmar, DE
NPI
1730389982
Since 2007
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
4
Medicare group memberships
Hospitals
5
Hospital affiliations
38552 Sussex Hwy
Delmar, DE, 19940
Phone (302) 846-0618
Groups this clinician bills Medicare through
Medicare paid, 2024
$153K
2,045 services
Medicare patients, 2024
524
Average age 73
Drug cost, 2024
$151K
463 prescriptions
Company payments, 2025
$172
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Makondo Shimukowa was code 99232 (hospital e&m - subsequent), 1,170 times for 392 patients. In total Makondo Shimukowa billed 2,045 services in 18 codes, and Medicare paid $153K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-04-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 1,170 | 392 | $61.87 | $72K |
| 99222 Hospital E&M - Initial | Facility | 371 | 308 | $92.98 | $34K |
| 99213 Office E&M - Established | Office | 186 | 120 | $72.12 | $13K |
| 99223 Hospital E&M - Initial | Facility | 181 | 170 | $131.25 | $24K |
| 99233 Hospital E&M - Subsequent | Facility | 44 | 34 | $93.55 | $4,116 |
| 99231 Hospital E&M - Subsequent | Facility | 42 | 33 | $37.72 | $1,584 |
| 99203 Office E&M - New | Office | 14 | 14 | $74.11 | $1,037 |
By year: 2022 $139K for 2,059 services; 2023 $152K for 1,862 services; 2024 $153K for 2,045 services.
Medicare prescription drug claims, 2024
In 2024, the drug Makondo Shimukowa prescribed most often to Medicare patients was Ceftriaxone (Ceftriaxone Sodium), with 68 prescriptions and refills. In total Makondo Shimukowa wrote 463 Medicare prescriptions that cost $151K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ceftriaxone Ceftriaxone Sodium | 68 | 68 | 25 | $26K |
| Vancomycin Hcl Generic | 45 | 46 | 17 | $9,307 |
| Daptomycin Generic | 36 | 36 | Under 11 | $65K |
| Cefepime Hcl Generic | 29 | 29 | 13 | $5,339 |
| Doxycycline Hyclate Generic | 22 | 39 | 16 | $503 |
| Ertapenem Ertapenem Sodium | 21 | 21 | Under 11 | $11K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 17 | 21 | Under 11 | $103 |
| Cefdinir Generic | 16 | 24 | 11 | $435 |
| Imipenem-Cilastatin Sodium Imipenem/Cilastatin Sodium | 14 | 14 | Under 11 | $3,011 |
| Cefazolin Sodium Generic | 13 | 13 | Under 11 | $1,033 |
| Azithromycin Generic | 13 | 13 | Under 11 | $305 |
| Cephalexin Generic | 12 | 16 | Under 11 | $442 |
| Amoxicillin Generic | 12 | 14 | Under 11 | $98.35 |
| Fluconazole Generic | 11 | 11 | Under 11 | $62.34 |
| Penicillin V Potassium Generic | 11 | 11 | Under 11 | $45.16 |
Brand drugs: 41 claims; generic drugs: 422 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Makondo Shimukowa $172 ($172 in general payments such as food, travel and fees) from 4 companies. The largest payer was ViiV Healthcare Company with $70.66.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.